|
Market Closed -
Xetra
23:35:32 02/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 359.10 EUR | -2.41% |
|
+0.01% | +28.11% |
| 10-03 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 218B 194B 181B 165B 311B 20,947B 314B 2,187B 847B 10,708B 818B 800B 34,367B | P/E 2026 * |
25.5x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 259B 230B 215B 196B 370B 24,935B 373B 2,603B 1,009B 12,747B 974B 953B 40,910B | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.29x |
| Free-Float |
99.77% | Yield 2026 * |
2.5% | Yield 2027 * | 2.64% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Börse Stuttgart
| AMG | Delayed | |
|
London S.E.
| 0R0T | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | -2.41% | ||
| 1 week | +0.01% | ||
| Current month | -3.77% | ||
| 1 month | -4.67% | ||
| 3 months | +10.49% | ||
| 6 months | +18.42% | ||
| Current year | +28.11% |
| 1 week | 357.5 |  | 376.75 |
| 1 month | 325.5 | | 381.65 |
| Current year | 271.8 | | 383.05 |
| 1 year | 247.65 | | 383.05 |
| 3 years | 230 | | 383.05 |
| 5 years | 174.58 | | 383.05 |
| 10 years | 120.65 | | 383.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.41% | +0.01% | - | - | 218B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.45% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | +0.26% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.6B 32.29B 29.43B 55.51B 3,743B 56.02B 391B 151B 1,914B 146B 143B 6,141B | 40.31B 35.81B 33.43B 30.47B 57.46B 3,875B 58B 405B 157B 1,981B 151B 148B 6,358B |
| Net income | 8.58B 7.62B 7.12B 6.49B 12.23B 825B 12.35B 86.11B 33.37B 422B 32.22B 31.52B 1,353B | 9.39B 8.35B 7.79B 7.1B 13.39B 903B 13.51B 94.26B 36.53B 462B 35.27B 34.5B 1,481B |
| Net Debt | 41.49B 36.86B 34.4B 31.36B 59.14B 3,988B 59.69B 416B 161B 2,039B 156B 152B 6,543B | 35.82B 31.82B 29.7B 27.07B 51.06B 3,443B 51.53B 359B 139B 1,760B 134B 132B 5,649B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €359.10 | -2.41% | 233 |
| 01/10/26 | €367.95 | -1.39% | 522 |
| 30/09/26 | €373.15 | +1.44% | 355 |
| 29/09/26 | €367.85 | +0.73% | 393 |
| 28/09/26 | €365.20 | +1.71% | 704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
Select your edition
All financial news and data tailored to specific country editions
